Key Highlights

  • The four names are ordered by size of pre-market gain on Wednesday, October 28, 2026: Davion Healthcare (NASDAQ:DAVI) at 39.00%, Wheeler Real Estate Investment Trust (NASDAQ:WHLR) at 13.74%, Aptevo Therapeutics (NASDAQ:APVO) at 11.72% and CBAK Energy Technology (NASDAQ:CBAT) at 9.57%.
  • Davion Healthcare (NASDAQ:DAVI) traded at USD 4.17 against a prior close near USD 3.00, which was a decline of about 26% to 32% on Tuesday, October 27, 2026, depending on the base used, and the company remains pre-revenue.
  • Wheeler Real Estate Investment Trust (NASDAQ:WHLR) traded at USD 0.3220 after second quarter 2026 revenue of USD 22.5 million, and Aptevo Therapeutics (NASDAQ:APVO) traded at USD 1.43 after transplant data released on Monday, October 26, 2026.
  • CBAK Energy Technology (NASDAQ:CBAT) traded at USD 0.9533 following a weaker snapshot on Tuesday. For Wheeler, Aptevo and CBAK, the Tuesday decline rests on pre-market snapshots, not on closing prices.

Davion Healthcare (NASDAQ:DAVI): a rebound in a new listing after a sharp fall

Irish company Davion Healthcare Plc (NASDAQ:DAVI), which is developing non-invasive home screening tests, was at USD 4.17 pre-market on Wednesday, October 28, 2026, a gain of 39.00% on the snapshot. Simple arithmetic implies a prior close near USD 3.00. The previous session had closed well below the pre-market level of about USD 3.71 seen on Tuesday, October 27, 2026, so the move reverses part of that decline. No company-specific announcement dated on or just before Wednesday, October 28, 2026 came with it. Thin liquidity in a listing that began trading on Thursday, October 22, 2026 seems to explain the bounce.

The release of Monday, October 26, 2026 reported the purchase of Humaskan intellectual property for USD 2.5 million in cash and 1,730,770 new shares at a fixed value of USD 13.00 each. Because the share count is fixed, the value delivered to the sellers moves with the market price. The company reported no revenue in its registration statement of Friday, December 5, 2025, and it launched a GBP 30 million five-year senior secured bond. Dilution, wide daily swings and regulatory scrutiny of tests described as non-diagnostic are the bearish points. The share issue is due on Wednesday, January 20, 2027.

Wheeler Real Estate Investment Trust (NASDAQ:WHLR): a sub-USD 1.00 REIT rebounds on thin liquidity

Wheeler Real Estate Investment Trust (NASDAQ:WHLR) is a real estate investment trust, or REIT, that owns and runs retail centres. It traded at USD 0.3220, up 13.74%, in pre-market trading on Wednesday, October 28, 2026. A pre-market snapshot on Tuesday, October 27, 2026 had the stock lower, so this move reverses that direction. No company-specific announcement came with the advance, which therefore seems consistent with thin liquidity and the volatility of a stock priced well under USD 1.00. The most recent formal disclosure was the company's release of Thursday, August 6, 2026.

That release covered the three months to Tuesday, June 30, 2026: total revenue of USD 22.476 million, net income of USD 9.746 million and funds from operations, a REIT earnings measure that adds back depreciation, of USD 11.540 million. Combined occupancy was 93.2%. Total debt principal of USD 471.697 million compares with cash of USD 31.873 million, roughly twenty-one times quarterly revenue by simple arithmetic. Bulls point to stable occupancy and progress on Series D preferred redemptions. Bears point to leverage, adjusted funds from operations of only USD 2.439 million and Nasdaq minimum bid price compliance.

Aptevo Therapeutics (NASDAQ:APVO): transplant data and a recovery from the prior snapshot

Multispecific antibodies for blood cancers and solid tumours are the focus of Aptevo Therapeutics (NASDAQ:APVO), a clinical-stage biotechnology company. In pre-market trading on Wednesday, October 28, 2026 it was at USD 1.43, up 11.72%. The gain reverses the pre-market decline of Tuesday, October 27, 2026 and implies a prior close near USD 1.28 by simple arithmetic on the snapshot. Its freshest company item is the release of Monday, October 26, 2026 at 8:05 a.m. ET, reporting that 10 of 47 patients given the mipletamig combination in acute myeloid leukaemia went on to donor stem cell transplant. Nothing dated Tuesday or Wednesday was identified, so the recovery may also reflect thin liquidity.

Cash and equivalents of USD 9.8 million at June 30, 2026 were reported in the quarterly update of Friday, August 14, 2026, and an inducement and placement in August 2026 raised about USD 4.5 million gross at USD 4.03 a share. Bulls point to the earlier 93% clinical benefit rate in frontline TP53-mutated disease. Bears point to small patient numbers, modest cash and dilution. Regulatory discussion is planned for the first half of 2027, and the SITC Annual Meeting runs from Wednesday, November 4, 2026 to Sunday, November 8, 2026.

CBAK Energy Technology (NASDAQ:CBAT): a battery maker bouncing below USD 1.00

Lithium-ion battery cells for light electric vehicles, energy storage and backup power are made by CBAK Energy Technology (NASDAQ:CBAT). It traded at USD 0.9533 pre-market on Wednesday, October 28, 2026, up 9.57%, following a pre-market decline of 5.74% to USD 0.79 on Tuesday, October 27, 2026. No company-specific announcement dated on or just before the session came with the move, and the latest release is dated Wednesday, October 14, 2026. Thin pre-market liquidity and a rebound in low-priced stocks look consistent with the advance, an inference.

First quarter 2026 net revenues rose 99.3% to USD 69,617,992, with gross profit of USD 1,039,868 and a net loss attributable to shareholders of USD 9,287,372. Cash was USD 9,338,921. Second quarter and third quarter results are not part of the figures cited. Bulls point to the order book, including about USD 96 million from an Indian two and three-wheeler maker. Bears point to a gross margin of 1.5% and a 12 GWh Nanjing project that depends on financing. A price near USD 1.00 is general context for Nasdaq minimum bid standards, not a disclosed notice.

Where Things Stand

The answer is that the rebounds look driven by thin trading after weaker sessions more than by new disclosure. Davion Healthcare (NASDAQ:DAVI) is recovering part of a sharp fall in a new listing, Wheeler Real Estate Investment Trust (NASDAQ:WHLR) is trading in a sub-USD 1.00 quote, and Aptevo Therapeutics (NASDAQ:APVO) has dated transplant data but no newer release. CBAK Energy Technology (NASDAQ:CBAT) completes the group with a modest bounce from Tuesday.

The next catalysts are the Federal Reserve decision due later on Wednesday, October 28, 2026, the SITC meeting from Wednesday, November 4, 2026 and the Davion share issue on Wednesday, January 20, 2027. Pre-market prices are snapshots that can change before the open at 9:30 a.m. ET, and this is not investment advice.